Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-27

FDA Approved: LIRAGLUTIDE — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Teva's liraglutide generic under Original Application (ANDA 214568). The approval covers the same indications as the reference product for type 2 d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

ORIG AP for LIRAGLUTIDE (LIRAGLUTIDE)